Enhanced ranking of PknB inhibitors using data fusion methods

Journal of Cheminformatics

Volumn 5, Issue 1, 2013, Pages

  Seal, Abhik ^a   Yogeeswari, Perumal ^b   Sriram, Dharmaranjan ^b   Wild, David J ^a  

^a INDIANA UNIVERSITY   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

BEDROC; Data fusion; PknB; Reciprocal rank; Virtual screening

Indexed keywords

EID: 84876717968     PISSN: None     EISSN: 17582946     Source Type: Journal    
DOI: 10.1186/1758-2946-5-2     Document Type: Article

References (60)

1. Walburger A, Koul A, Ferrari G, Nguyen L, Prescianotto-Baschong C, Huygen K: Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 2004, 304:1800-1804. (Pubitemid 38787896)
2. Szekely R, Waczek F, Szabadkai I, Nemeth G, Hegymegi-Barakonyi B, Eros D: A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling. Immunol Lett 2008, 116:225-231.
3. Sassetti CM, Boyd DH, Rubin EJ: Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003, 48:77-84. (Pubitemid 36411469)
4. Young TA, Delagoutte B, Endrizzi JA, Falick AM, Alber T: Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases. Nat Struct Biol 2003, 10:168-174. (Pubitemid 36297985)
5. Ortiz-Lombardia M, Pompeo F, Boitel B, Alzari PM: Crystal structure of the catalytic domain of the PknB serine/threonine kinase from Mycobacterium tuberculosis. J Biol Chem 2003, 278:13094-13100. (Pubitemid 36800077)
6. Fernandez P, Saint-Joanis B, Barilone N, Jackson M, Gicquel B, Cole ST, Alzari PM: The Ser/Thr protein Kinase PknB Is Essential for Sustaining Mycobacterial Growth. J Bacteriol 2006, 188(22):7778. doi:10.1128/JB.00963-06. Published Ahead of Print 15 September 2006.
7. Madhusudan, Akamine P, Xuong NH, Taylor SS: Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase. Nat Struct Biol 2002, 9:273-277. (Pubitemid 34289899)
8. Goldberg J, Nairn AC, Kuriyan J: Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell 1996, 84:875-887. (Pubitemid 26106857)
9. Niefind K, Guerra B, Ermakowa I, Issinger OG: Crystal structure of human protein kinase Ck2: Insights into basic properties of the Ck2 holoenzyme. EMBO J 2001, 20:5320-5331. (Pubitemid 32959451)
10. Huse M, Kuriyan J: The conformational plasticity of protein kinases. Cell 2002, 109:275-282. (Pubitemid 34606870)
11. Chapman MT, Bouloc N, Buxton SR: Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. Bioorg Med Chem Lett 2012, 22:3349-3353.
12. Szekely R, Waczek F, Szabadkai I: A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signaling. Immunol Lett 2008, 116:225-231.
13. Barakonyi HB, Szekely R, Varga Z, Kiss R: Signalling Inhibitors Against Mycobacterium tuberculosis - Early Days of a New Therapeutic Concept in Tuberculosis. Curr Med Chem 2008, 15:2760-2770.
14. Lougheed EAK, Osborne AS, Saxty B: Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents. Tuberculosis (Edinb) 2011, 91(4):277-286. Epub 2011 Apr 11.
15. Wehenkel A, Fernandez P, Bellinzoni M, Catherinot V, Barilone N, Labesse G, Jackson M, Alzari PM: FEBS Lett 2006, 580:3018. PDB ref: 2FUM.
16. Clark DE: What has Virtual screening ever done for drug discovery? Exp. Opin. Drug Discovery 2008, 3:841-851.
17. Lee HS, Choi J, Kufareva I, Abagyan R, Filikov A, Yang Y, Yoon S: Optimization of High throughout VS by Combining Shape-Matching and Docking Methods. J Chem Inf Model 2008,48:489-497 (Pubitemid 351535418)
18. Schierz CA: Virtual screening of Bioassay data. Journal of Cheminformatics 2009, 1:21
19. Seal A, Passi A, Jaleel UCA, Wild DJ, OSDD Consortium: Insilco predictive Mutagenicity model generation using supervised learning approaches. Journal of Cheminformatics 2012, 4:10.
20. Willett P: Similarity-based Virtual screening using 2D fingerprints. Drug Discov Today 2006, 11 (23-24):1046-1053. (Pubitemid 44792477)
21. Maggiora GM, Shanmugasundaram V: Molecular similarity measures. Meth Mol Biol 2010, 672:39-100.
22. Kitchen BD, Decornez H, Furr RJ, Bajorath J: Docking and scoring in Virtual screening in Drug Discovery: Methods and Applications. Nat Rev Drug Discov 2004 Nov, 3(11):935-949i.
23. Charifson PS, Corkery JJ, Murcko MA, Walters WP: Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem 1999, 42:5109
24. Liu S, Rao F, Zhou HL, Chen PS: Application of Consensus Scoring and Principal Component analysis for Virtual screening against β-Secretase (BACE-1). PLoS One 2012, 7(6):e38086.
25. Miklos F: Consensus scoring for protein-ligand interactions. Drug Discov Today 2006, 11(9-10)421-428. doi:ISSN 1359-6446.
26. Leach AR, Shoichet BK, Peishoff CE: Prediction of Protein - Ligand Interactions Docking and scoring: Successes and Gaps. J Med Chem 2006, 49:5851-5855. (Pubitemid 44484931)
27. Peter W: Enhancing the Effectiveness of Ligand-Based Virtual screening using data Fusion. QSAR Comb Sci 2006, 25:1143-1152.
28. Nasr RJ, Swamidass SJ, Baldi PF: Large scale study of multiple-molecule queries. Journal of Cheminformatics 2009, 1:7.
29. Ginn CMR, Willett P, Bradshaw J: Combination of molecular similarity measures using data fusion. Perspect Drug Discov Des 2000, 20(1):1-16
30. Tan L, Geppert H, Sisay MT, Gütschow M, Bajorath J: Integrating Structure- and Ligand-Based virtual screening: Comparison of Individual, Parallel, and Fused Molecule a Docking and Similarity Search calculations on Multiple Targets. Chem Med Chem 2008, 3:1566-1571
31. Fredrik S, Anders K, Christian S: Virtual screening Data Fusion Using Both Structure- and Ligand-Based Methods. J Chem Inf Model 2012, 52(1)225-232.
32. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL: Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004, 47:1750-1759. (Pubitemid 38380918)
33. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT: Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006, 49:6177-6196. (Pubitemid 44595196)
34. Sheridan RP, Singh SB, Fluder EM, Kearsley SK: Protocols for bridging the peptide to nonpeptide gap in topological similarity searches. J Chem Inf Comput Sci 2001, 41:1395-1406.
35. Truchon J-F: Bayly CI: Evaluating VS Methods: Good and Bad Metrics for the "EarlyRecognition" Problem. J Chem Inf Model 2007, 47:488-508 (Pubitemid 46615951)
36. Chemaxon: Budapest H. Marvin for end User s5.10.3.; 2012. August 2012.
37. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS: Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004,47:1739-1749 (Pubitemid 38380917)
38. Salam NK, Nuti R, Sherman W: Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis. J Chem Inf Model 2009, 49:2356-2368.
39. Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Freisner RA: PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D databases screening: 1 Methodology and preliminary results. J Comput Aided Mol Des 2006, 20:647-671 (Pubitemid 46023928)
40. ROCS, 2.3.1: OpenEye Scientific Software. http://www.eyesopen.com/rocs. Santa Fe, NM.
41. OMEGA, 2.3.1: OpenEye Scientific Software. http://www.eyesopen.com/omega. Santa Fe, NM.
42. Boström J, Greenwood JR, Gottfries J: Assessing the performance of OMEGA with respect to retriving bioactive conformations. J. Mol. Graphics Model 2003, 21:449-462. (Pubitemid 36120775)
43. Baber JC, Shirley WA, Gao Y, Feher M: The Use of Consensus Scoring in Ligand-Based Virtual screening. J Chem Inf Model 2006, 46:244-288.
44. Whittle M, Gillet VJ, Willet P: Analysis of Data Fusion Methods in VS: Theoretical Model. J Chem Inf Model 2006, 46:2193-2205. (Pubitemid 46008095)
45. Whittle M, Gillet VJ, Willet P: Analysis of Data Fusion Methods in VS: Similarity and Group Fusion. J Chem Inf Model 2006, 46:2206-2219. (Pubitemid 46008096)
46. Svensson F, Karlen A, Skold C: VS Data Fusion Using Both Structure and Ligand Based Methods. J Chem Inf Model 2012, 52:225-232.
47. Cormack GV, Clarke CLA, Buettcher S: Reciprocal rank fusion outperforms condorcet and individual rank learning methods, Proceedings of the 32nd international ACM SIGIR conference on Research and development in information retrieval (SIGIR '09). New York, NY, USA: ACM; 2009:758-759.
48. Nuray R, Can F: Automatic ranking of information retrieval systems using data fusion. Inf Process Manag 2006, 42:595-614. (Pubitemid 41563153)
49. Güner OF, Henry DR: Pharmacophore perception, development, and use in drug design, IUL Biotechnology Series. In Metric for analyzing hit lists and pharmacophores. Edited by Güner OF. La Jolla, CA: International University Line; 2000:191-212.
50. Güner OF, Waldman M, Hoffmann RD, Kim JH, Güner OF: Pharmacophore perception, development, and use in drug design, IUL Biotechnology Series. In Strategies for database mining and pharmacophore development. 1st edition. La Jolla: International University Line; 2000:213-236.
51. Langer T, Hoffmann RD: Pharmacophores and pharmacophore searches. Weinheim: WILEY-VCH; 2006:338-340.
52. Lu SH, Wu JW, Liu HL, Zhao JH, Liu KT, et al: The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies. J Biomed Sci 2011, 18:8.
53. Zhao W, Hevener KE, White SW, Lee RE, Boyett JM: A statistical framework to evaluate virtual screening. BMC Bioinformatics 2009, 10:225.
54. Triballeau N, Acher F, Brabet I, Pin J, Bertrand H: VS workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 2005, 48(7):2534-2547. (Pubitemid 40520517)
55. Nikolas F, Andreas J, Georg H, Andreas Z: Estimation of the applicability domain of kernel-based machine learning models for Virtual screening. Journal of Cheminformatics 2010, 2:2.
56. Zuccotto F, Ardini E, Casale E, Angiolini M: Through the "GateKeeper Door": Exploiting the Active Kinase Conformation. J Med Chem 2010, 53:2681-2694.
57. Zhang J, Yang LP, Gray SN: Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009, 9:28-39.
58. O'Shea R, Moser HE: Physicochemical properties of antibacterial compounds implications for drug discovery. J Med Chem 2008, 51:2871-2878. (Pubitemid 351706014)
59. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. AdV. Drug DeliVery ReV 1997, 23:3-25. (Pubitemid 27046991)
60. Steinbeck C, Han Y, Kuhn S, Horlacher O, Luttmann E, Willighagen E: The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics. J Chem Inf Comput Sci 2003, 43(2):493-500.